Healthtech startup FutureCure Health has raised around $4 million in Series A funding from RVCF India Growth Fund, Unicorn India Ventures, Kotak Investment Advisors Limited, and other investors.
The company plans to use the funds to further develop various technologies, FDA approvals, and global expansion.
Founder Rajneesh Bhandari, serial entrepreneur and IIT Delhi alumnus, said that FutureCure is developing cutting-edge technologies to diagnose and treat chronic diseases like migraine, dizziness, etc. The startup plans to launch various technologies for migraine patients, including wearable neuromodulation and biofeedback device. In addition, the digital therapeutics app will help identify the triggers using AI and help manage lifestyle changes. The interactive app will also provide Cognitive Behavioral Therapy (CBT), it said.
Jaipur-based Healthtech startup FutureCure Health was founded in 2019 by Rajneesh Bhandari and Dr. Anita Bhandari, the husband-wife engineer-doctor pair.
“Migraine affects over 12 percent of the global population. The incidence is much higher than diabetes or cardiac disease, especially in the age group of 20 to 50 years, which are the most productive years of a person’s life. Technological interventions by FutureCure will help millions of patients manage their Migraine and other chronic diseases”, said, Dr. Anita Bhandari, FutureCure’s Co-Founder, ENT surgeon and Neurotologist.
“Inaccurate diagnosis and treatment for ailments such as dizziness and migraine is a problem faced by both developing and developed parts of the world”, said, Dhiraj Rajendran of KIAL.
FutureCure’s vision is to provide super-specialty healthcare through state-of-the-art emerging technologies.
“FutueCure technology ensures that migraines’ triggers are identified and treated to bring down the frequency of the headache. This is a major breakthrough and a brilliant use case for applying technologies to make lives better at scale. For Unicorn India Ventures, it matches our investment thesis that resulted in us leading the round in the Company”, said, Anil Joshi, Managing Partner, Unicorn India Ventures.
“FutureCure’s model, coupling AI technology with a strong clinic network, is a market leader in providing on-demand migraine and dizziness diagnostic and treatment services and changing the way for millions of patients across the world”, said, Gaurav Chowdhry, Vice President, RVCF India Growth Fund.
